Actinium Pharmaceuticals reported $-7670000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Actinium Pharmaceuticals ATNM:US $ -7670000 2.64M
Amgen AMGN:US $ 3004M 337M
Capricor Therapeutics CAPR:US $ -5.71M 0.23M
Pfizer PFE:US $ 12921M 1739M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Spectrum Pharmaceuticals SPPI:US $ -25.32M 11.33M